PAVmed Inc. Material Event - What Happened

Hey there! Let's break down what's going on with PAVmed Inc. in a way that makes sense, without all the confusing finance talk. Think of this as me telling you the latest news over coffee.

---

1. What happened? (The actual event, in plain English)

Okay, so here's the scoop: PAVmed just announced they're doing a reverse stock split at a ratio of 1-for-30. This means for every 30 shares of PAVmed stock you currently own, you'll now have 1 share. At the same time, they're also significantly reducing the total number of shares they're allowed to issue (from 250 million to 25 million). Think of it like taking a big pizza and cutting it into fewer, larger slices – you still have the same amount of pizza, just fewer pieces.

2. When did it happen?

This all went down on December 30, 2025, when the company officially filed the paperwork. The changes, including the stock split, will actually become effective and start trading on a split-adjusted basis on Friday, January 2, 2026, at 12:01 a.m. Eastern Time.

3. Why did it happen? (The context and background)

So, why did this happen? Well, it looks like PAVmed is doing this to keep its stock listed on the Nasdaq stock exchange. Nasdaq has a rule that a company's stock price needs to stay above $1 per share. PAVmed received a warning back on January 23, 2025, because their stock price had dropped below that $1 mark for too long. They were given time to fix it, first until July 22, 2025, and then an extension until January 19, 2026. By doing a reverse stock split, they expect the price per share to go up (since there are fewer shares), helping them meet that $1 minimum requirement. Basically, they're taking a necessary step to avoid being delisted from a major stock exchange.

4. Why does this matter? (The impact and significance)

Alright, so why should you care about this? This event is a big deal because it's crucial for PAVmed to maintain its listing on Nasdaq. Being listed on a major exchange like Nasdaq helps the company attract investors, makes it easier for people to buy and sell their stock, and generally boosts their credibility. If they were delisted, it could make it much harder for them to raise money or for investors to trade their shares. While a reverse split doesn't change the total value of the company initially, it's a strategic move to ensure they stay in the game and maintain investor confidence by meeting exchange requirements.

5. Who is affected?

Who's feeling this?

• PAVmed itself: Obviously, the company is directly impacted. This move helps them stay listed on Nasdaq, which is vital for their reputation, ability to raise capital, and overall business operations.
• Their customers (patients and doctors): Not directly affected by this financial maneuver. Their access to PAVmed's products remains the same.
• Their employees: Staying listed on Nasdaq can contribute to the company's stability and growth prospects, which indirectly benefits employees through job security and potential future opportunities.
• Investors (that's you!): This is where it gets direct. If you own 30 shares, you'll now own 1 share, but that one share will theoretically be worth 30 times more than a single share was before the split. Your total investment value should remain the same right after the split, but the stock price will look higher. It's a necessary step to keep the stock trading on Nasdaq, which is generally seen as a positive for long-term investors.
• Maybe even the broader medical industry: Not directly affected by this specific financial action.

6. What happens next? (Immediate and future implications)

So, what's the game plan now? We can expect PAVmed's stock to start trading on a split-adjusted basis on January 2, 2026. The company will then need to maintain its stock price above the $1 minimum bid requirement to fully regain compliance with Nasdaq. Over the next few weeks/months, keep an eye out for how the stock performs post-split and any further announcements from Nasdaq regarding their listing status.

7. What should investors/traders know? (Practical takeaways)

Okay, for those of you watching your portfolios, here's the practical stuff:

• For current shareholders: Don't be alarmed by seeing fewer shares in your account; the value per share will be proportionally higher. This action is primarily about keeping the company listed on Nasdaq, which is generally a good thing for the long-term health and tradability of your investment.
• For potential investors/traders: While the stock price will appear higher, remember that the underlying company value hasn't changed just because of the split. It's a technical move to meet listing requirements. It might make the stock look more "respectable" to some, but always look at the company's fundamentals.
• Key takeaway: This reverse stock split is a strategic move by PAVmed to ensure it remains listed on Nasdaq, addressing a critical compliance issue. It doesn't change the company's fundamental value, but it's important for its market presence and investor access.

Remember: Always do your own research and consider your personal financial situation. This is just the gist of what you need to know right now to understand the "so what?" of this event!